GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharmocann Global Ltd (XTAE:PMCN-M) » Definitions » Forward Dividend Yield %

Pharmocann Global (XTAE:PMCN-M) Forward Dividend Yield % : 0.00% (As of May. 24, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Pharmocann Global Forward Dividend Yield %?

As of today (2024-05-24), the Forward Annual Dividend Yield of Pharmocann Global is 0.00%.

As of today (2024-05-24), the Trailing Annual Dividend Yield of Pharmocann Global is 0.00%.

XTAE:PMCN-M's Forward Dividend Yield % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.855
* Ranked among companies with meaningful Forward Dividend Yield % only.

Pharmocann Global's Dividends per Share for the three months ended in Dec. 2023 was ₪0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Pharmocann Global's Forward Dividend Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Pharmocann Global's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmocann Global's Forward Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pharmocann Global's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Pharmocann Global's Forward Dividend Yield % falls into.



Pharmocann Global Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Pharmocann Global  (XTAE:PMCN-M) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Pharmocann Global Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Pharmocann Global's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmocann Global (XTAE:PMCN-M) Business Description

Traded in Other Exchanges
N/A
Address
Ramat Yishai, PO Box 305, Kiryat Tivon, ISR, 3601201
Pharmocann Global Ltd is an Israel-based company engaged in producing medical-related cannabis products which include oil, ointments, tablets, inhalers, rectal and vaginal suppositories, and pre-rolled cigarettes of various types of THC/CBD strains.

Pharmocann Global (XTAE:PMCN-M) Headlines

No Headlines